ELAVL1-KO Affects Steroid Synthesis in ACC Cell Line NCI-H295R and Reduces Colony-Forming Abilities

Area of Science:

• Oncology
• Molecular Biology
• Endocrinology

Background:

• Adrenocortical carcinoma (ACC) is a rare adrenal gland cancer with limited treatment options for advanced stages.
• Embryonic-Lethal-Abnormal-Vision-Like RNA-Binding Protein 1 (ELAVL1) expression is linked to poorer patient survival in ACC.
• Understanding ELAVL1's functional role is crucial for developing novel ACC therapies.

Purpose of the Study:

• To investigate the functional role of ELAVL1 in adrenocortical carcinoma.
• To characterize the transcriptomic and steroidogenic consequences of ELAVL1 deficiency in ACC cells.

Main Methods:

• CRISPR/Cas9 gene editing was used to create ELAVL1 knockout (KO) ACC cell lines (NCI-H295R, HAC15).
• Next-Generation RNA Sequencing (NGS) analyzed transcriptomic alterations in ELAVL1-deficient cells.
• Steroid profiling assessed changes in hormone synthesis in KO cells.

Main Results:

• ELAVL1 depletion significantly altered gene expression, upregulating 3468 and downregulating 3458 genes in NCI-H295R cells.
• KEGG pathway analysis revealed enrichment in aldosterone biosynthesis and downregulation in "pathways in cancer."
• ELAVL1-KO cells showed reduced colony formation, increased aldosterone synthesis, and decreased cortisol and androgen production.

Conclusions:

• ELAVL1 deficiency impairs ACC cell proliferation and alters steroid hormone production.
• ELAVL1 plays a significant role in ACC pathogenesis and steroidogenesis.
• ELAVL1 inhibition presents a potential therapeutic strategy for adrenocortical carcinoma.